Announcing UDITracker 3.0

Champion Healthcare Technologies, a leading provider of tissue and implant management solutions since 2006, is pleased to announce UDITracker 3.0 and its new features, integrations, and controls. UDITracker 3.0 is a modern and automated platform for managing even the most complex tissue and implant operations.

Among the many benefits are:

  • An inviting user experience that is aligned with hospital processes and workflows to simplify tissue and implant management.
  • Integrations with GUDID and our large data library make it easy to expand UDITracker’s product library and add new products for tracking.
  • The ability to optimize the tissue and implant management process across the supply chain in real time—at one hospital location and across an entire health system.

Sign up here to receive announcements of our upcoming "UDITracker 3.0 reveal" webinar to take place in Q1 2020.


Implant Management to Address $25.7B Supply Chain Savings Opportunity

Response to Navigant Report

November 2019

Focus on Implant Management to Address a $25.7 Billion Supply Chain Savings Opportunity

 

Craig Lan
Craig Lan
Vice President,
Product Management

According to Navigant's annual Healthcare Supply Chain Report1, hospitals can safely reduce their supply chain expenses by an average of 17.4% or $12.1 million annually. This represents an increase of 22.6% from 2017 and equates to an annual cumulative savings of $25.7 billion. The analysis further reveals that equal savings opportunities exist across multiple hospital characteristics, including size, location, and for-profit or not-for-profit status.

The clear takeaway from Navigant's findings is that despite current efforts by hospitals and health systems to optimize supply chain processes and product utilization, creative tactics and solutions are still needed -and I couldn't agree more.

Implants, though just one segment of the overall supply chain, can represent up to 30% of a hospital's total supply spend2. Expensive on their own, sometimes accounting for more than 50% of the cost of procedures, implants can be a major source of additional expenditures if not managed closely. According to the Global Healthcare Exchange, hospitals and suppliers nationwide lose up to $5 billion in implantable devices annually because of waste and ineffective processes3.

From my experience working with hospitals and supply chain leaders across the country, I see tremendous opportunity to improve the management of implantable tissues and devices in three key areas - to both yield financial savings and to improve the quality and safety of patient care:

  1. Reduce waste
    Many hospitals continue to use homegrown systems in an effort to track implants, from receipt of items through use in patient procedures. While these solutions perform the job of detailed tracking, they typically do not highlight areas where waste is excessive. For implants, common sources of waste include Expiration, Loss, and Items Used but not Billed for. Software that monitors inventory closely can greatly reduce these types of waste.
  2. Optimize inventory levels
    Hospitals need to manage inventory levels to avoid the risk of stock-outs and to avoid carrying too much inventory. By effectively tracking inventory, supply chain managers can stay within optimal inventory levels, simultaneously minimizing the risk of running out of items, and avoiding an unnecessary quantity of expensive implants.An additional inventory consideration, specific to implants, is the need for hospitals to diligently monitor device recalls. By ensuring the facility is notified of recalls quickly, supply chain managers can remove items from stock to avoid threatening patient safety scenarios.
  3. Reduce clinical variation
    Variation in implants used exists in every complex health system. With the sheer number of options for implant types available to clinicians, different implants that serve the same clinical purpose are used. Sometimes this variation is warranted when a strong clinical reason exists, but other times clinicians may not realize there are lower cost and equal value alternatives. By tracking implants used for identical procedures and comparing these over time, supply chain managers can better inform clinicians about the cost side of the equation when such expensive variability exists.

To address the above opportunities, hospitals will need to invest in a software solution that enables the unique tracking and management requirements of tissue and device implants. A solution with strong predictive analytics and reporting, recall matching, and monitoring of device usage and variation are just a few fundamental features to look for. It is the right time for the status quo of supply chain management to be challenged-and implants are an important place to start.

Footnotes
1. "Annual Supply Chain Savings Opportunity Reaches $25.7 Billion for U.S. Hospitals, Navigant Analysis Finds," Navigant, November 2019
2. Taken from the Navigant 2019 report (1), total supply chain spend includes: medical and implantable device costs, medical/surgical and pharmaceutical supplies charged to patient care departments, and supplies related to buildings/fixtures, maintenance, and plant operations
3. "Industry's Achilles Heel: The Supply Chain," Global Healthcare Exchange (GHX), 2013


Champion Healthcare Technologies Receives Investment from The Riverside Company

Champion and HemaTerra combine to create a leading medical specialty software company

CHICAGO - June 6, 2019 - Champion Healthcare Technologies (Champion), a SaaS provider that enables hospitals to manage surgical implants throughout their life cycle – from receipt, inventory storage, and usage, to post-surgical tracking and reporting -- received investment from The Riverside Company, a global private equity firm. Through the investment, Champion is combining with HemaTerra Technologies (HemaTerra), a provider of SaaS-based solutions for independent and hospital-based blood collection centers and plasma collection centers. Riverside made an investment in HemaTerra earlier this year.

“We are thrilled to partner with The Riverside Company and to combine with HemaTerra,” says Champion’s Co-founder Peter Casady. “We look forward to continuing to make an impact on implant management through improved patient safety and hospital cost savings.”

Champion’s industry-leading solutions are used by many of the largest and most sophisticated health systems in the U.S. Through deep integration with vendors, system-wide visibility into implants, and robust analytics, Champion’s implant management software helps customers improve patient safety, reduce costs, and maintain compliance. The combined company will serve over 500 hospitals and many of the leading independent blood and plasma collection centers in the U.S.

“The combination of our companies will not only enable us to accelerate our growth in the hospital market but also to better serve our customers through new and innovative product development and expanded service offerings,” says Champion’s President, Maria Siambekos.

Champion chose to partner with Riverside, given its strong track record and commitment to investing in software and healthcare companies. To date, the firm has completed more than 150 investments in these areas and has a team of global experts dedicated to growing companies in these specializations.

“By combining with Champion, who share our approach of providing top-notch healthcare specialty software, we look forward to optimizing the healthcare supply chain. We are in a unique and exciting position to connect key supply chain stakeholders, including blood banks, tissue banks, hospitals, manufacturers, donors, and volunteers,” says HemaTerra CEO Todd Collins.

 

Refer all media inquires to: Maria Siambekos, President, Champion Healthcare Technologies (1-866-803-3720)

--

About The Riverside Company

The Riverside Company is a global private equity firm focused on investing in growing businesses valued at up to $400 million. Since its founding in 1988, Riverside has made more than 600 investments. The firm's international private equity and structured capital portfolios include more than 90 companies.

 

About HemaTerra Technologies

HemaTerra provides industry-leading software that integrates to provide blood, plasma, and hospital organizations with a broad view of their supply chain for complete operations management. The suite of products assists customers with hospital order entry, donor recruitment, mobile drives, collections staffing, product QC, and equipment maintenance. Integration removes the barriers of information across departments so that customers can seamlessly run their entire operations.

 

About Champion Healthcare Technologies

Founded in 2005, Champion provides comprehensive implant management solutions to over 500 hospitals and health systems. Its broad portfolio enables organizations to effectively track and manage implants throughout their life cycle (i.e., receipt to explant) to improve patient safety, reduce costs, and minimize risk. Through deep integration with vendors, system-wide visibility into implants, and robust analytics, Champion empowers organizations to drive meaningful results.


Hospitals Still Fall Short in Pursuing Claims for Recalled CRM Devices

Response to OIG Report

January 8, 2019

Hospitals Still Fall Short in Pursuing Claims for Recalled CRM Devices

 

Paul Cicciarelli, Product Manager, Champion Healthcare Technologies

In 2018, the Office of Inspector General (OIG) published a report citing that 210 hospitals did not always comply with Medicare requirements for reporting certain cardiac device manufacturer credits.

Specifically, all 296 payments reviewed by the OIG for recalled cardiac medical devices did not follow Medicare requirements for reporting manufacturer credits. Medicare contractors incorrectly paid hospitals $7.7 million for cardiac device replacement claims rather than the $3.3 million they should have been paid, resulting in potential overpayments of $4.4 million. The OIG contributes these overpayments to Medicare controls not being sufficient to ensure that hospitals properly reported manufacturer credits for cardiac devices.

Though an eye-opening report, this is not the first time the OIG has highlighted its concern about medical device credits. OIG estimated that from 2005 to 2014, services related to the replacement of recalled and prematurely-failed medical devices cost Medicare $1.5 billion. Given the widespread nature and heightened attention to noncompliance, hospitals need to take notice or otherwise risk facing substantial overpayment fines in an audit.

Hospitals’ path towards compliance, however, does not come without challenges. Below are some challenges that my colleagues and I at Champion have observed for hospitals to properly identify, track, and report credits to Medicare:

  1.     The process for identifying, tracking, and reporting medical device credits on Medicare claims requires many different hospital departments and staff disciplines (materials management, accounts payable, clinical departments, etc.). For example, separate hospital personnel are responsible for contacting the manufacturer, tracking the availability of the credit, and determining whether an adjustment claim needs to be submitted to pass along the credit to Medicare. Staff need to ensure very close coordination and open communication to be successful.
  2.     It is the hospital, not the manufacturer, that is responsible for initiating the warranty credit process. However, complex documentation make this difficult for staff. For instance, hospitals are faced with many types of submission forms, as each manufacturer has a distinct device return authorization process that requires details in varying formats. Furthermore, hospital staff submitting Medicare claims must be aware of credits that are at least 50 percent of the price the facility paid for the replacement device, and must report the credit as a deduction on a submitted claim.
  3.     Another challenge is that hospitals often do not know whether they will receive a credit or how much that credit will be at the time of billing for the device replacement procedure. In these ambiguous situations, the hospital has two options. First, the hospital may hold the claim until a determination is made about the credit and then submit the claim with the appropriate condition code and value code or modifier if it receives a reportable credit. Or, the hospital may submit the claim immediately without a condition code and value code or modifier, and if the hospital receives a reportable credit later, submit an adjustment claim with the appropriate condition code and value code or modifier. Either option may work, but they both underscore how onerous pursing credits can be, particularly if hospitals do not have policies and procedures in place.

Ensuring compliance and reducing audit risk for hospitals is paramount, but it’s clear from these examples that challenges and confusion around pursuing credits still exist.

I encourage you to read more about the complexities of medical device warranty credits in Champion’s 3-part white paper series:

  • Part 1: Awareness and Understanding (download here). Discover the challenges of the process, the cost of noncompliance, and critical components to reduce audit risk.
  • Part 2: Policy and Oversight (download here). Read about the importance of developing a device warranty policy, as well as tips and pitfalls for overseeing the claims process.
  • Part 3: Standard Processes and Procedures (coming soon). Leveraging knowledge from Parts 1 and 2, understand the processes and procedures needed to comply with device warranty claims requirements.

Champion Gives Back to Celebrate Customer Service Week 2018

Champion Healthcare Technologies joined with customer service professionals in all 50 states and over 60 countries in celebrating Customer Service Week, October 1st-5th!

The week provided an opportunity for us to focus on the importance of customer service to our organization and to the individuals we serve each day. Equally important, it was a time to recommit to our customer support mission - Deliver world class customer support and training with integrity and simplicity that will meet and exceed our customers' expectations

To celebrate the end of the week we were lucky enough to join Feed My Starving Children, a non-profit organization, that let us volunteer to pack scientifically formulated meals for malnourished children. Feed My Starving Children distributes to over 200 partners in 50 countries and Champion's team completed packing 12,960 meals that will feed 35 children for one year!

A huge thank you to every department who is committed to making our customer's feel appreciated and heard day in and day out. It was a wonderful week and our staff was exemplary of this years theme, "Excellence Happens Here"!


Champion Healthcare Technologies CEO Peter Casady to Present at the Association for Healthcare Resource and Materials Management 2018 Conference

AHRMM18 Presentation to Discuss Warranty Credit Requirements and Best Practices to Mitigate Risk

CHICAGO - August 7, 2018 - Champion Healthcare Technologies, an implant tracking and inventory management company, announced today that Peter Casady, founder and chief executive officer, will present alongside Tyler Fredericksen, category analyst, Centura Health, at AHRMM18. The Learning Lab session entitled, "Navigating OIG Audits for Device Overpayments: Best Practices" will be held on Tuesday, August 14th at 1:00 p.m. CT.

"Errors in device warranty credit tracking and reporting can leave hospitals at risk of an OIG audit and liable for significant penalties," said Peter Casady, CEO, Champion Healthcare Technologies. "It can be challenging because the process is typically very fragmented and lacks transparency. However, with the right procedures and systems, we believe hospitals can significantly streamline workflow and increase visibility throughout the process to reduce risk."

The session will include a discussion about Centers for Medicare and Medicaid Services (CMS) requirements, Office of Inspector General (OIG) audits and the resulting financial penalties around incorrectly reporting medical device warranty credits. The presenters will describe best practices for internal processes and procedures to effectively manage claims to reduce risk and ensure compliance. In addition, Fredericksen will provide an overview of Centura Health's approach to streamline the workflow and create transparency throughout the process to enable stakeholders across the organization to be more efficient.

ARHMM18 is scheduled for August 12-15th in Chicago, IL. In addition to the presentation, Champion Healthcare Technologies will also be exhibiting at Booth #223. For more information, visit www.championht.com/events/ahrmm18-conference-exhibition.

About Champion Healthcare Technologies
Champion Healthcare Technologies provides comprehensive implant tracking and inventory management solutions. Its broad portfolio helps hospitals and health systems effectively track and manage tissue and implants throughout the enterprise to ensure compliance, optimize efficiency and improve patient safety and quality. Leveraging a deep integration with vendors, government entities and other systems, Champion empowers healthcare organizations with greater transparency and visibility. For more information, visit us at www.ChampionHT.com or follow us on LinkedIn and Twitter.


Champion Healthcare Technologies Launches Software Pilot to Address Medicare Overpayments

CHICAGO, Aug. 1, 2017 /PRNewswire/ - Champion Healthcare Technologies ("Champion"), a healthcare information technology company and leader in tissue tracking and medical device management systems (MDMS) for hospitals, in collaboration with Mayo Clinic, has developed a warranty management system to address Medicare overpayments for the replacement of defective medical implants. The Warranty Tracker™ system is currently being piloted at three Mayo Clinic campuses in Rochester, MN, Jacksonville, FL and Phoenix, AZ.

Warranty Tracker™ helps providers automate and streamline the warranty reimbursement process for implanted medical devices including pacemakers and defibrillators, cochlear implants, and neuro stimulators. The Centers for Medicare and Medicaid Services (CMS), requires hospitals to obtain available credits from manufacturers for replaced medical devices and to keep records of the credits they receive. Currently a provider must undergo a complex series of manual steps without clear visibility into the reimbursement status of returned devices in order to receive full or partial credit from manufacturers for devices that are covered under warranty. Providers are subject to audit by the Office of Inspector General (OIG) and want to ensure the reimbursements from manufacturers are up to date and accurate.

In October 2016, The Wall Street Journal reported the U.S. government "spent $1.5 billion in taxpayer dollars to treat 375,000 Medicare patients who received faulty cardiac implants.1" OIG audits confirm overpayments to providers due to issues including improper tracking of device warranty credits from manufacturers. These credits can amount to thousands of dollars per patient and CMS can levy fines to hospitals it judges noncompliant in securing warranty credits which are due without applying those credits to the patient's bill.

"We're very proud to work with Mayo Clinic to provide hospitals with a management tool that solves the complex problem of capturing warranty reimbursement dollars and document refunds to Medicare for overpayments on replacement devices," said Peter Casady, Chief Executive Officer of Champion Healthcare Technologies. "The Warranty Tracker solution draws on Champion's core expertise developing medical device management systems that improve patient safety and compliance and reduce hospital operating costs."

Under the agreement, Champion and Mayo co-developed the warranty credit management software and conducted beta testing at Mayo Clinic.

"The process for tracking device warranties can be challenging due to many touchpoints and we at Mayo Clinic have been proactive to improve the processes and efficiency," says Paul Friedman, M.D., a cardiologist at Mayo Clinic who has collaborated on the project.

Champion holds the exclusive global marketing license. The warranty credit management solution, Warranty Tracker™, can be incorporated as a module in Champion's UDITracker® Interventional or UDITracker® OR software solutions.
Mayo Clinic and Dr. Paul Friedman have a financial interest in the technology referenced in this news release. Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education and research.

1Wall Street Journal - Oct 19, 2016 https://www.wsj.com/articles/a-better-way-to-find-faulty-pacemakers-1476916626

About Champion Healthcare Technologies
Champion Healthcare Technologies is a privately held, healthcare information technology company and leader in tissue tracking and implantable medical device management systems (MDMS) for hospitals. Champion's flagship system UDITracker® captures, documents and shares medical implant information between patient care and supply chain information systems, empowering hospitals with the insights they need to increase patient safety and drive down operating costs.


Vysnova Partners Teams with Champion Healthcare Technologies to Provide Air Force Implant and Tissue Tracking Software

Washington, D.C. (March, 2017)-Vysnova Partners and Champion Healthcare Technologies were recently awarded the Department of Defense (DOD) Air Force medical tissue tracking contract.

Vysnova will serve as the prime and Champion as the subcontractor on the project, which will deploy a commercial off the shelf (COTS) best-in-class software system programmed to track implants and tissues across four Air Force bases.

"We are excited to be working with Champion to support the Air Force by implementing software that is vital to ensuring compliance and patient safety," said Carlos Rivera, Vysnova CEO. "Vysnova has experience working across DOD programs, and we look forward to expanding the scope of our work with the Air Force."

The tracking solution automates the entire chain of custody for tracking tissue and implants - from the loading dock until each is implanted in a patient. The program provides Joint Commission compliance for tissue as well as a Meaningful Use 3 solution in capturing Unique Device Identification (UDI) information for all implants ranging from orthopedic to dental. The software is a user-friendly, barcode scanning application that will help the DOD eliminate manual documentation and challenging expiration and recall investigation processes.

"We are honored to be working with the Department of Defense and specifically the Air Force on this project," said Pete Casady, Champion Healthcare Technologies CEO. "Our service will provide peace of mind to the valuable men and women who serve and defend our country."

The software can be used at any DOD location at which healthcare procedures involving implants are performed. With the new software, these facilities will meet Food and Drug Administration (FDA), DOD and other regulatory requirements, including the 2015 Department of Health and Human Services (HHS) mandate that requires UDIs in electronic health records.

Three locations have already been installed, with one more location to be added by May 2017.

About Champion Healthcare Technologies
Champion Healthcare Technologies is a privately held, healthcare information technology company and leader in tissue tracking and implantable medical device management systems (MDMS) for hospitals. Champion's flagship system, UDITracker®, captures, documents and shares medical implant information between patient care and supply chain information systems, empowering hospitals with the insights they need to increase patient safety and drive down operating costs.
UDITracker® is a comprehensive medical device management system that integrates regulatory compliance, inventory management, quality assurance, warranty credit management, and product recall inventory and patient matching into a single, streamlined system. Using barcode scanners, smartphone apps and RFID storage units, users capture accurate and complete medical device label information in a single swipe to ensure patient safety, produce inventory cost savings and to generate business-decision making analytics.
RecallConnect®, the only real-time recall inventory and patient matching system on the market, received a Chicago Innovation Award in recognition of its unique patient safety feature. It reduces from months to hours the amount of time it takes hospitals to identify patients and current inventory affected by a medical device product recall.
Founder and Chief Executive Officer Peter Casady established Champion Healthcare Technologies in 2006. Today, it serves hospitals and major medical centers nationwide and is the market leader in tissue compliance and medical device management. For more information, visit championht.com.

About Vysnova Partners
Vysnova Partners, Inc. teams with federal agencies to develop and implement government operations and acquisition solutions, as well as global public health initiatives. With a diverse team of project managers and subject matter experts who have worked both with and within the federal government, Vysnova has experienced our customers' challenges first hand. With that experience, Vysnova develops and delivers successful operational solutions for federal agencies. Whether it's Zika prevention research with the CDC in Colombia or developing curriculum for the Defense Acquisition University (DAU) stateside, Vysnova executes proven solutions so its customers are able to focus on their core missions. As one of the few government contractors with project implementation experience in every continent, Vysnova knows how to initiate and conduct business internationally to keep its customers in compliance while advancing the project and the broader mission that it serves. For more information, visit Vysnova.com.